trending Market Intelligence /marketintelligence/en/news-insights/trending/bXRitJwwbb3xwq8Dn4ImZg2 content esgSubNav
In This List

Cancer Genetics enters hereditary breast, ovarian cancer testing market

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Cancer Genetics enters hereditary breast, ovarian cancer testing market

Cancer Genetics Inc. is entering the hereditary breast and ovarian cancer diagnostics market with the launch of a focused genomic panel to detect such cancers in the human body.

The panel, termed Focus::HERSite, will initially focus on analyzing the 16 most common genes associated with the cancers.

The company estimates that the U.S. market for hereditary breast and ovarian cancer testing is approximately $2.5 billion today and growing at 7% annually.